News
DGAP-News: Deutsche Industrie REIT-AG erwirbt Light Industrial Objekte in Damsdorf, Dinslaken und Wedemark
DGAP-News: Deutsche Industrie REIT-AG erwirbt Light Industrial Objekte in Damsdorf, Dinslaken und Wedemark
DGAP-News: Dermapharm Holding SE treibt Unternehmenswachstum im dritten Quartal 2019 weiter voran
DGAP-News: Dermapharm Holding SE treibt Unternehmenswachstum im dritten Quartal 2019 weiter voran
DGAP-News: Dermapharm Holding SE continues to drive the company's growth in the third quarter of 2019
DGAP-News: Dermapharm Holding SE continues to drive the company's growth in the third quarter of 2019
DGAP-News: Deutsche Industrie REIT-AG legt das Volumen für Kapitalerhöhung fest
DGAP-News: Deutsche Industrie REIT-AG legt das Volumen für Kapitalerhöhung fest
DGAP-News: Deutsche Industrie REIT-AG sets volume of capital increase
DGAP-News: Deutsche Industrie REIT-AG sets volume of capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG sells 100% of the shares from the capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG sells 100% of the shares from the capital increase
DGAP-Adhoc: Deutsche Industrie REIT-AG: 100 % der Aktien der Deutsche Industrie REIT-AG aus der Kapitalerhöhung platziert
DGAP-Adhoc: Deutsche Industrie REIT-AG: 100 % der Aktien der Deutsche Industrie REIT-AG aus der Kapitalerhöhung platziert
DGAP-News: Deutsche Industrie REIT-AG - Preliminary subscription quota: 44.6 % of the new shares subscribed for in the subscription offer - Start of private placement
DGAP-News: Deutsche Industrie REIT-AG - Preliminary subscription quota: 44.6 % of the new shares subscribed for in the subscription offer - Start of private placement
DGAP-News: Deutsche Industrie REIT-AG - Vorläufige Bezugsrechtsquote 44,6 % der neuen Aktien der im Rahmen des Bezugsangebots bezogen - Beginn der Privatplatzierung
DGAP-News: Deutsche Industrie REIT-AG - Vorläufige Bezugsrechtsquote 44,6 % der neuen Aktien der im Rahmen des Bezugsangebots bezogen - Beginn der Privatplatzierung
DGAP-Adhoc: Deutsche Industrie REIT-AG sets subscription price at EUR 16.25 per new share
DGAP-Adhoc: Deutsche Industrie REIT-AG sets subscription price at EUR 16.25 per new share
DGAP-Adhoc: Deutsche Industrie REIT-AG legt Bezugspreis auf EUR 16,25 je neuer Aktie fest
DGAP-Adhoc: Deutsche Industrie REIT-AG legt Bezugspreis auf EUR 16,25 je neuer Aktie fest
DGAP-Adhoc: Deutsche Industrie REIT-AG beschließt Kapitalerhöhung aus genehmigtem Kapital
DGAP-Adhoc: Deutsche Industrie REIT-AG beschließt Kapitalerhöhung aus genehmigtem Kapital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
DGAP-Adhoc: Deutsche Industrie REIT-AG resolves capital increase from authorized capital
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE builds on success in Q3 2023
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: outstanding start to financial year 2023
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
EQS-News: Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma